Evaluation of SARS-CoV-2-positive patients with suspected reinfection

dc.authorid0000-0002-3572-0062
dc.contributor.authorAllahverdiyeva, Aytaj
dc.contributor.authorAğaçfidan, Ali
dc.contributor.authorDoğan, Lerzan
dc.contributor.authorÖnel, Mustafa
dc.contributor.authorKırkoyun Uysal, Hayriye
dc.contributor.authorMedetalibeyoğlu, Alpay
dc.contributor.authorŞenkal, Naci
dc.contributor.authorAlaskarov, Elvin
dc.contributor.authorMeşe, Sevim
dc.date.accessioned2023-12-13T07:21:11Z
dc.date.available2023-12-13T07:21:11Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kulak Burun Boğaz Hastalıkları Ana Bilim Dalı
dc.description.abstractThe aim of this study was to investigate the reinfection rates and characteristics of SARS-CoV-2 in individuals with SARS-CoV-2 RNA present in their clinical specimens for COVID-19. Our data from the COVID-19 Laboratory of Istanbul University were analyzed for 27,240 cases between 27 March 2020 to 8 February 2022. Demographic characteristics, vaccination statuses, comorbidities, and laboratory findings were evaluated in cases with suspected reinfection, as determined by the presence of SARS-CoV-2 RNA at a rate of 0.3% in clinical specimens. When comparing laboratory values, leukocyte counts were lower in the second and third infections compared with the first infection (p = 0.035), and neutrophil counts were lower in the second infection (p = 0.009). Symptoms varied, with coughing being common in the first infection and malaise being common in subsequent infections. These results suggest that it is important to continue to monitor reinfection rates and develop strategies to prevent reinfection. Our results also suggest that clinicians should be aware of the possibility of reinfection and monitor patients for recurrent symptoms.
dc.identifier.citationAllahverdiyeva, A., Ağaçfidan, A., Doğan, L., Önel, M., Kırkoyun Uysal, H., Medetalibeyoğlu, A. ... Meşe, S. (2023). Evaluation of SARS-CoV-2-positive patients with suspected reinfection. Viruses, 15(11). https://dx.doi.org/10.3390/v15112222
dc.identifier.doi10.3390/v15112222
dc.identifier.issn1999-4915
dc.identifier.issue11
dc.identifier.pmid38005899
dc.identifier.scopus2-s2.0-85177763732
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://dx.doi.org/10.3390/v15112222
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11986
dc.identifier.volume15
dc.identifier.wos001121007700001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAlaskarov, Elvin
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.ispartofVirusesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectRT-PCR
dc.subjectReinfection
dc.titleEvaluation of SARS-CoV-2-positive patients with suspected reinfection
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Alaskarov-Elvin-2023.pdf
Boyut:
1.01 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: